WELCOME TO The PHARMACEUTICAL REPORT
Home > News >
Trending news >
NICE recommends Roche’s Tecentriq combo for certain lung cancer patients
pharmaphorum | May 03, 2019
Injection systems that are attached to the patient's body (on-body delivery system OBDS) minimize possible risks, that can occur when drugs are administered by conventional needle-based injection systems (NIS).
Dom Nicastro | April 03, 2020
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE